Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Promising 2-year updated data from cadonilimab presented at 2023 ASCO highlighting promising efficacy in PD-L1-negative patients 2023-06-06 19:04
2023 ASCO | Multi-center Data for Combination Study of GenFleet's GFH018 (TGF-β R1 inhibitor) with Anti-PD-1 Antibody Demonstrates Significant Potential to Enhance Efficacy of Immune Checkpoint Inhibitors among ICI-naïve Patients 2023-06-06 19:00
Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025 2023-06-06 19:00
Midea Healthcare Unveils New Solutions for Smart Healthcare Market 2023-06-06 16:10
Biosyngen's Cell Therapy BRG01 Granted Orphan Drug Designation by the U.S. FDA for Treatment of Nasopharyngeal Cancer 2023-06-06 12:58
Live from ASCO 2023 | Ascentage Pharma Releases Updated Data Showing APG-2449's Potential as a New Treatment for Drug-Resistant NSCLC 2023-06-06 12:20
Live from ASCO 2023 | Ascentage Pharma Releases the First Dataset of Lisaftoclax in WM, Revealing Encouraging Therapeutic Potential 2023-06-06 10:45
Alphamab Oncology updated clinical research data for KN026 in Combination with KN046 in HER2-Positive Solid Tumors at the ASCO 2023 annual meeting 2023-06-06 09:06
Telix to Present at Jefferies Healthcare Conference 2023-06-06 08:40
Transcenta Presents Updated Data of Osemitamab (TST001) in Combination with CAPOX as a First-Line Treatment of G/GEJ Cancer at 2023 ASCO Annual Meeting 2023-06-06 08:20
Scientific Research Report Highlights Medit i700 wireless, Medit i700, and Medit i600 as Top Intraoral Scanners in Dentistry 2023-06-06 08:00
Innovent Presents Phase 1 Clinical Data of IBI351 (KRASG12C Inhibitor) as Monotherapy for Metastatic Colorectal Cancer at the 2023 ASCO Annual Meeting 2023-06-06 08:00
Innovent and IASO Bio Updated Efficacy and Safety Clinical Data of Equecabtagene Autoleucel (BCMA CAR-T Cell Therapy) for Multiple Myeloma at the 2023 ASCO Annual Meeting 2023-06-06 08:00
Cali Biosciences Initiates Second Phase III Study of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use and Presents Consistent and Predictable PK Results Across Multiple Surgeries 2023-06-06 00:00
Russellville Hospital and United Imaging Announce First Installation in the U.S. of the 4 cm uCT(R) ATLAS Computed Tomography Scanner 2023-06-05 22:00
ASCO 2023: RemeGen Exhibits Promising Results of Disitamab Vedotin in Bladder Cancer 2023-06-05 21:26
RemeGen Demonstrates Profitability to Successfully Receive Approval from the Hong Kong Stock Exchange to Upgrade Stock Short Name 2023-06-05 21:17
Fresh2 Group Ltd. Announces US$4.4 Million Private Placement 2023-06-05 21:00
Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure 2023-06-05 21:00
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing 2023-06-05 20:00
1 188 189 190 191 192 970